Milestone Pharmaceuticals, Inc. (MIST)
0.8097
-0.01
(-0.74%)
USD |
NASDAQ |
Oct 02, 16:00
0.8036
-0.01
(-0.75%)
After-Hours: 20:00
Milestone Pharmaceuticals Price : 0.8097 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 0.8159 | 0.8308 | 0.7921 | 0.8097 | 769552.0 |
| Oct 01, 2026 | 0.88 | 0.8965 | 0.8101 | 0.8157 | 725594.0 |
| Sep 30, 2026 | 0.838 | 0.8975 | 0.82 | 0.8657 | 1.269M |
| Sep 29, 2026 | 0.783 | 0.8279 | 0.7799 | 0.82 | 933568.0 |
| Sep 28, 2026 | 0.7809 | 0.8199 | 0.78 | 0.7954 | 419540.0 |
| Sep 25, 2026 | 0.80 | 0.8150 | 0.7521 | 0.7884 | 1.265M |
| Sep 24, 2026 | 0.8799 | 0.8799 | 0.78 | 0.7949 | 2.325M |
| Sep 23, 2026 | 0.925 | 0.925 | 0.8506 | 0.862 | 1.529M |
| Sep 22, 2026 | 0.92 | 0.929 | 0.891 | 0.921 | 1.721M |
| Sep 21, 2026 | 0.927 | 0.9289 | 0.9004 | 0.9178 | 674000.0 |
| Sep 18, 2026 | 0.91 | 0.94 | 0.8964 | 0.9158 | 563177.0 |
| Sep 17, 2026 | 0.92 | 0.9386 | 0.895 | 0.9196 | 980617.0 |
| Sep 16, 2026 | 0.93 | 0.94 | 0.8841 | 0.8892 | 1.569M |
| Sep 15, 2026 | 0.9682 | 0.9732 | 0.90 | 0.9277 | 1.948M |
| Sep 14, 2026 | 0.99 | 1.035 | 0.9401 | 0.9494 | 2.583M |
| Sep 11, 2026 | 1.06 | 1.081 | 0.98 | 0.9801 | 3.324M |
| Sep 10, 2026 | 1.07 | 1.08 | 1.05 | 1.05 | 1.107M |
| Sep 09, 2026 | 1.13 | 1.14 | 1.07 | 1.07 | 1.315M |
| Sep 08, 2026 | 1.20 | 1.215 | 1.12 | 1.125 | 1.794M |
| Sep 04, 2026 | 1.21 | 1.26 | 1.195 | 1.20 | 1.593M |
| Sep 03, 2026 | 1.22 | 1.26 | 1.195 | 1.21 | 2.029M |
| Sep 02, 2026 | 1.14 | 1.185 | 1.14 | 1.18 | 767736.0 |
| Sep 01, 2026 | 1.14 | 1.155 | 1.115 | 1.14 | 1.020M |
| Aug 31, 2026 | 1.17 | 1.17 | 1.14 | 1.16 | 1.004M |
| Aug 28, 2026 | 1.20 | 1.205 | 1.14 | 1.16 | 865687.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| InMed Pharmaceuticals, Inc. | 1.33 |
| NervGen Pharma Corp. | 1.78 |
| Clearmind Medicine, Inc. | 0.715 |
| Lexaria Bioscience Corp. | 2.88 |
| Target Group, Inc. (Canada) | 0.0007 |
Price Related Metrics
| PS Ratio | 40.75 |
| Price to Book Value | 5.533 |
| Earnings Yield | -85.69% |
| Market Cap | 100.81M |